Alphatec Holdings (ATEC) Narxning foydaga nisbati

Alphatec Holdings (ATEC) korporativ emblemasi va logotipi

Alphatec Holdings, Inc. (ATEC) neyroxirurglar uchun kompleks yechimlarni ishlab chiqadi va vertebrologiya sohasidagi o'z mavqeini kengaytirmoqda. Kompaniyaning P/E koeffitsiyenti tahlili bozor kutganlarini baholash imkonini beradi, bunda -12.50 ushbu parametrning joriy holatini belgilaydi. Yuqori marjalar noyob davolash metodologiyalari orqali erishiladi, robototexnika va neymonitoring tizimlarining agressiv joriy etilishi esa sanoatning eng yirik gigantlaridan bozor ulushini egallashni ta'minlaydi.

Alphatec Corp (ATEC) Narx-foyda koeffitsiyenti: 04.07.2022 - 15.11.2026 davri uchun

Alphatec (ATEC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:Alphatec Holdings - ATEC
atecspine.com original mahsuloti

Yuqori texnologik tizimlarni vertebrologiyaga integratsiya qiluvchi Alphatec Holdings, Inc. (ATEC) uchun B2B savdoning kengayish samaradorligi kapitalizatsiyaga bevosita ta'sir ko'rsatadi. P/E koeffitsiyenti aksiyalarning bozor qiymatini har bir aksiya uchun sof foyda bilan solishtirib, daromadning har bir dollari narxini va aktivning haddan tashqari qimmat baholanganlik darajasini aniqlaydi. Alphatec Holdings, Inc. (ATEC) ning P/E trayektoriyasini tahlil qilish orqali investor stagnatsiya xavfi va o'sishning haddan tashqari qimmat baholanishi o'rtasidagi muvozanatni saqlagan holda, adolatli narx koridorlarini aniqlaydi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|CooperSurgical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Group (TMDX)|AORT (Artivion) - P/E multiplikatori|Narx-foyda multiplikatori ENOV (Enovis)|Narx-foyda koeffitsiyenti IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati iLet Bionic Pancreas BBNX|IRMD - Narx-foyda koeffitsiyenti|Embecta Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tandem Diabetes Care|AXGN: P/E multiplikatori|Narx-foyda multiplikatori SIBN|OFIX (Orthofix Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti Bioventus Corp (BVS)|P/E multiplikatori KIDS|Narx-foyda koeffitsiyenti Treace Medical Concepts TMCI|P/E multiplikatori SRTA (blade.com)|P/E multiplikatori Carlsmed, Inc. CARL|RXST - Narxning foydaga nisbati|CLPT: Narxning foydaga nisbati|STXS (Stereotaxis, Inc.) - Narx-foyda koeffitsiyenti|Neuronetics, Inc. - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Orchestra BioMed Inc. OBIO|Narxning foydaga nisbati Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical International Ltd. - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani VANI|Xtant Medical Holdings, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati NeuroOne NMTC|Modular Medical, Inc. (MODD) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Myomo, Inc|Narxning foydaga nisbati envoymedical.com|Narx-foyda koeffitsiyenti Vivos Therapeutics (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)